FDA Contracting for ‘Fresh’ Aborted Baby Tissue to Engineer Humanized Mice
The federal Food and Drug Administration (FDA) has contracted with
Advanced Bioscience Resource (ABR) – a biomedical company referred for
federal criminal investigation – to provide “fresh” aborted baby tissue
to engineer humanized mice for drug experimentation.
A new report from CNSNews.com
quotes an FDA notice dated June 13 to the U.S. Department of Health and Human Services (HHS), which oversees the FDA:
The Government intends to solicit and negotiate directly
with Advanced Bioscience Resources (ABR) Inc. and no solicitation will
be issued. The objective is to acquire Tissue for Humanized Mice. ABR is
the only company that can provide the human fetal tissue needed to
continue the ongoing research being led by the FDA. Fresh human tissues
are required for implantation into severely immune-compromised mice to
create chimeric animals that have a human immune system. This human
immune system allows us to test biological drug products for safety and
efficacy.
According to the
Congressional Research Service, “Fetal tissue used in research is obtained from elective abortions.”
REST OF ARTICLE HERE:
No comments:
Post a Comment